Profiles of copper intrauterine devices and levonorgestrel intrauterine systems users in France in 2019: A national observational population‐based study
International Journal of Gynecology & Obstetrics · 2023-02 · 160 (2) · 594-603
DOI: 10.1002/ijgo.14438 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 10.09.2022. Verfasst von Noémie Roland und 5 weiteren Autor:innen. Beteiligte Einrichtung: EPI-PHARE (French National Agency for Medicines and Health Products Safety, ANSM; and French National Health Insurance, CNAM), Saint-Denis Cedex, Fra…. Hauptthemen laut MEDLINE: Intrauterine Devices, Copper, Contraceptive Agents, Female, Intrauterine Devices, Medicated. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
To assess the user profiles of copper intrauterine devices (Cu‐IUD) and levonorgestrel intrauterine systems (LNG‐IUS) in France in 2019 and the rates of continuation 1 year later.
Methods
A population‐based study was conducted of all French women aged 13–49 years for whom an IUD was dispensed in 2019. Information was collected from the French National Health Data System about their characteristics at the time of dispensation and indicators of continued use 1 year later. Associations between these characteristics and the type of IUD were analyzed using multivariate regressions.
Results
A total of 477 705 Cu‐IUDs and 355 242 LNG‐IUSs (mean age 32.5 ± 7.3 and 36.4 ± 7.7 years, respectively) were dispensed in 2019. After adjustment, having a LNG‐IUS rather than a Cu‐IUD was associated with being aged 35–44 years compared to 25–35 years (odds ratio [OR 35–44 ] 2.03, 95% confidence interval [CI] 2.01–2.05), having a prescription by a gynecologist rather than a general practitioner (OR 35–44 1.09, 95% CI 1.08–1.11), and having a gynecological history (OR 35–44 2.28, 95% CI 2.20–2.36). The continuation rates 1 year after dispensation were 86.4% for Cu‐IUD versus 85.7% for LNG‐IUS. A Cu‐IUD dispensation rather than a LNG‐IUS one was associated with a higher chance of continued use 1 year later.
Conclusion
Two different patterns of use of Cu‐IUDs and LNG‐IUSs in France are highlighted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- EPI-PHARE (French National Agency for Medicines and Health Products Safety, ANSM; and French National Health Insurance, CNAM), Saint-Denis Cedex, France.
- University Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Anti-infective Evasion and Pharmacoepidemiology, Center for Research in Epidemiology and Population Health (CESP), Montigny le Bretonneux, France.
- Adolescent and Young Adult Gynaecology Unit and Reference Center for Rare Diseases of Genital Development, APHP Paris Saclay University, Bicêtre Hospital, Le Kremlin Bicêtre, France.
ORCID-Profile: Noémie Roland, Bérangère Baricault, Rosemary Dray-Spira, Alain Weill, Lise Duranteau, Mahmoud Zureik
Zitieren
APA
Roland, N., Baricault, B., Dray-Spira, R., Weill, A., Duranteau, L., & Zureik, M. (2023). Profiles of copper intrauterine devices and levonorgestrel intrauterine systems users in France in 2019: A national observational population‐based study. International Journal of Gynecology & Obstetrics, 160(2), 594-603. https://doi.org/10.1002/ijgo.14438
Vancouver
Roland N, Baricault B, Dray-Spira R, Weill A, Duranteau L, Zureik M. Profiles of copper intrauterine devices and levonorgestrel intrauterine systems users in France in 2019: A national observational population‐based study. International Journal of Gynecology & Obstetrics. 2023;160(2):594-603. doi:10.1002/ijgo.14438
BibTeX
@article{Roland2023,
author = {Roland, Noémie and Baricault, Bérangère and Dray-Spira, Rosemary and Weill, Alain and Duranteau, Lise and Zureik, Mahmoud},
title = {Profiles of copper intrauterine devices and levonorgestrel intrauterine systems users in France in 2019: A national observational population‐based study},
journal = {International Journal of Gynecology & Obstetrics},
year = {2023},
volume = {160},
number = {2},
pages = {594--603},
doi = {10.1002/ijgo.14438}
}
EUVIMED